Van Nieuwenhuysen, E
119  Ergebnisse:
Personensuche X
?
6

197TiP First-in-human (FIH) phase I/II study of ubamatamab,..:

Moore, K.N. ; Bouberhan, S. ; Hamilton, E....
Immuno-Oncology and Technology.  16 (2022)  - p. 100309 , 2022
 
?
7

Features of durable response and treatment efficacy for cap..:

Thijssen, S. ; Wildiers, H. ; Punie, K....
Journal of Cancer Research and Clinical Oncology.  147 (2021)  4 - p. 1041-1048 , 2021
 
?
8

Robot-assisted surgery for women with endometrial cancer: S..:

Kakkos, A. ; Ver Eecke, C. ; Ongaro, S....
European Journal of Surgical Oncology.  47 (2021)  5 - p. 1117-1123 , 2021
 
?
9

Curative effect of second curettage for treatment of gestat..:

Vandewal, A. ; Delbecque, K. ; Van Rompuy, A.S....
European Journal of Obstetrics & Gynecology and Reproductive Biology.  257 (2021)  - p. 95-99 , 2021
 
?
10

Treatment efficacy and predictors of durable response to ca..:

Thijssen, S. ; Wildiers, H. ; Punie, K....
European Journal of Cancer.  138 (2020)  - p. S65-S66 , 2020
 
?
11

Phase 2 study of the Exportin 1 inhibitor selinexor in pati..:

Vergote, I.B. ; Lund, B. ; Peen, U....
Gynecologic Oncology.  156 (2020)  2 - p. 308-314 , 2020
 
?
13

Palbociclib in highly pretreated metastatic ER-positive HER..:

Hoste, G. ; Punie, K. ; Wildiers, H....
Breast Cancer Research and Treatment.  171 (2018)  1 - p. 131-141 , 2018
 
?
14

Breast cancer subtype and survival by parity and time since..:

De Mulder, H. ; Laenen, A. ; Wildiers, H....
Breast Cancer Research and Treatment.  169 (2018)  3 - p. 481-487 , 2018
 
?
15

Efficacy of CDK 4/6 inhibition after fulvestrant in metasta..:

Hoste, G. ; Punie, K. ; Wildiers, H....
European Journal of Cancer.  92 (2018)  - p. S111-S112 , 2018
 
1-15